PrP(106-126) does not interact with membranes under physiological conditions

Biophysical Journal

Volumn 95, Issue 4, 2008, Pages 1877-1889

  Henriques, Sónia Troeira ^a   Pattenden, Leonard Keith ^b   Aguilar, Marie Isabel ^b   Castanho, Miguel A R B ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOSOME; MEMBRANE LIPID; PEPTIDE FRAGMENT; PHOSPHOLIPID; PRION PROTEIN (106 126); PRION PROTEIN (106-126);

ARTICLE; ARTIFICIAL MEMBRANE; BINDING SITE; CHEMISTRY; PRION; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

BINDING SITES; LIPOSOMES; MEMBRANE LIPIDS; MEMBRANES, ARTIFICIAL; PEPTIDE FRAGMENTS; PHOSPHOLIPIDS; PRIONS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 50349090857     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1529/biophysj.108.131458     Document Type: Article

References (67)

1. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA. 95:13363-13383.
2. Johnson, R. T. 2005. Prion diseases. Lancet Neurol. 4:635-642.
3. Naslavsky, N., H. Shmeeda, G. Friedlander, A. Yanai, A. H. Futerman, Y. Barenholz, and A. Taraboulos. 1999. Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions. J. Biol. Chem. 274:20763-20771.
4. Pinheiro, T. J. 2006. The role of rafts in the fibrillization and aggregation of prions. Chem. Phys. Lipids. 141:66-71.
5. Thellung, S., T. Florio, A. Corsaro, S. Arena, M. Merlino, M. Salmona, F. Tagliavini, O. Bugiani, G. Forloni, and G. Schettini. 2000. Intracellular mechanisms mediating the neuronal death and astrogliosis induced by the prion protein fragment 106-126. Int. J. Dev. Neurosci. 18:481-492.
6. Kourie, J. I. 2001. Mechanisms of prion-induced modifications in membrane transport properties: implications for signal transduction and neurotoxicity. Chem. Biol. Interact. 138:1-26.
7. Mironov, A., Jr., D. Latawiec, H. Wille, E. Bouzamondo-Bernstein, G. Legname, R. A. Williamson, D. Burton, S. J. DeArmond, S. B. Prusiner, and P. J. Peters. 2003. Cytosolic prion protein in neurons. J. Neurosci. 23:7183-7193.
8. Campana, V., D. Sarnataro, and C. Zurzolo. 2005. The highways and byways of prion protein trafficking. Trends Cell Biol. 15:102-111.
9. Forloni, G., N. Angeretti, R. Chiesa, E. Monzani, M. Salmona, O. Bugiani, and F. Tagliavini. 1993. Neurotoxicity of a prion protein fragment. Nature. 362:543-546.
10. Selvaggini, C., L. De Gioia, L. Cantu, E. Ghibaudi, L. Diomede, F. Passerini, G. Forloni, O. Bugiani, F. Tagliavini, and M. Salmona. 1993. Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. Biochem. Biophys. Res. Commun. 194:1380-1386.
11. Florio, T., S. Thellung, C. Amico, M. Robello, M. Salmona, O. Bugiani, F. Tagliavini, G. Forloni, and G. Schettini. 1998. Prion protein fragment 106-126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell line. J. Neurosci. Res. 54:341-352.
12. Fioriti, L., E. Quaglio, T. Massignan, L. Colombo, R. S. Stewart, M. Salmona, D. A. Harris, G. Forloni, and R. Chiesa. 2005. The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species. Mol. Cell. Neurosci. 28:165-176.
13. Salmona, M., G. Forloni, L. Diomede, M. Algeri, L. De Gioia, N. Angeretti, G. Giaccone, F. Tagliavini, and O. Bugiani. 1997. A neurotoxic and gliotrophic fragment of the prion protein increases plasma membrane microviscosity. Neurobiol. Dis. 4:47-57.
14. De Gioia, L., C. Selvaggini, E. Ghibaudi, L. Diomede, O. Bugiani, G. Forloni, F. Tagliavini, and M. Salmona. 1994. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein. J. Biol. Chem. 269:7859-7862.
15. Jobling, M. F., L. R. Stewart, A. R. White, C. McLean, A. Friedhuber, F. Maher, K. Beyreuther, C. L. Masters, C. J. Barrow, S. J. Collins, and R. Cappai. 1999. The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126. J. Neurochem. 73:1557-1565.
16. Brown, D. R., J. Herms, and H. A. Kretzschmar. 1994. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment. Neuroreport. 5:2057-2060.
17. Hope, J., M. S. Shearman, H. C. Baxter, A. Chong, S. M. Kelly, and N. C. Price. 1996. Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A β 25-35. Neurodegeneration. 5:1-11.
18. Pietri, M., A. Caprini, S. Mouillet-Richard, E. Pradines, M. Ermonval, J. Grassi, O. Kellermann, and B. Schneider. 2006. Overstimulation of PrPC signaling pathways by prion peptide 106-126 causes oxidative injury of bioaminergic neuronal cells. J. Biol. Chem. 281:28470-28479.
19. Lin, M. C., T. Mirzabekov, and B. L. Kagan. 1997. Channel formation by a neurotoxic prion protein fragment. J. Biol. Chem. 272:44-47.
20. Kourie, J. I., and A. Culverson. 2000. Prion peptide fragment PrP[106-126] forms distinct cation channel types. J. Neurosci. Res. 62:120-133.
21. Manunta, M., B. Kunz, E. Sandmeier, P. Christen, and H. Schindler. 2000. Reported channel formation by prion protein fragment 106-126 in planar lipid bilayers cannot be reproduced. FEBS Lett. 474:255-256.
22. Kunz, B., E. Sandmeier, and P. Christen. 1999. Neurotoxicity of prion peptide 106-126 not confirmed. FEBS Lett. 458:65-68.
23. Diomede, L., S. Sozzani, W. Luini, M. Algeri, L. De Gioia, R. Chiesa, P. M. Lievens, O. Bugiani, G. Forloni, F. Tagliavini, and M. Salmona. 1996. Activation effects of a prion protein fragment [PrP-(106-126)] on human leucocytes. Biochem. J. 320:563-570.
24. Ferreiro, E., R. Resende, R. Costa, C. R. Oliveira, and C. M. Pereira. 2006. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-β peptides neurotoxicity. Neurobiol. Dis. 23:669-678.
25. Fioriti, L., N. Angeretti, L. Colombo, A. De Luigi, A. Colombo, C. Manzoni, M. Morbin, F. Tagliavini, M. Salmona, R. Chiesa, and G. Forloni. 2007. Neurotoxic and gliotrophic activity of a synthetic peptide homologous to Gerstmann-Straussler-Scheinker disease amyloid protein. J. Neurosci. 27:1576-1583.
26. LeVine 3rd, H. 1993. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2:404-410.
27. Klunk, W. E., R. F. Jacob, and R. P. Mason. 1999. Quantifying amyloid β-peptide (Aβ) aggregation using the Congo red-Aβ (CR-Aβ) spectrophotometric assay. Anal. Biochem. 266:66-76.
28. Sabate, R., and J. Estelrich. 2003. Pinacyanol as effective probe of fibrillar β-amyloid peptide: comparative study with Congo red. Biopolymers. 72:455-463.
29. Bertsch, M., A. L. Mayburd, and R. J. Kassner. 2003. The identification of hydrophobic sites on the surface of proteins using absorption difference spectroscopy of bromophenol blue. Anal. Biochem. 313:187-195.
30. McParland, V. J., N. M. Kad, A. P. Kalverda, A. Brown, P. Kirwin-Jones, M. G. Hunter, M. Sunde, and S. E. Radford. 2000. Partially unfolded states of β (2)-microglobulin and amyloid formation in vitro. Biochemistry. 39:8735-8746.
31. Veiga, S., Y. Yuan, X. Li, N. C. Santos, G. Liu, and M. A. Castanho. 2006. Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions. Biochim. Biophys. Acta. 1760:55-61.
32. Ladokhin, A. S., S. Jayasinghe, and S. H. White. 2000. How to measure and analyze tryptophan fluorescence in membranes properly, and why bother? Anal. Biochem. 285:235-245.
33. Mayer, L. D., M. J. Hope, and P. R. Cullis. 1986. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta. 858:161-168.
34. Cooper, M. A., A. Hansson, S. Lofas, and D. H. Williams. 2000. A vesicle capture sensor chip for kinetic analysis of interactions with membrane-bound receptors. Anal. Biochem. 277:196-205.
35. Keller, C. A., K. Glasmastar, V. P. Zhdanov, and B. Kasemo. 2000. Formation of supported membranes from vesicles. Phys. Rev. Lett. 84:5443-5446.
36. Gaidukov, L., A. Fish, and A. Mor. 2003. Analysis of membrane-binding properties of dermaseptin analogues: relationships between binding and cytotoxicity. Biochemistry. 42:12866-12874.
37. Kamimori, H., K. Hall, D. J. Craik, and M. I. Aguilar. 2005. Studies on the membrane interactions of the cyclotides kalata B1 and kalata B6 on model membrane systems by surface plasmon resonance. Anal. Biochem. 337:149-153.
38. Mozsolits, H., and M. I. Aguilar. 2002. Surface plasmon resonance spectroscopy: an emerging tool for the study of peptide-membrane interactions. Biopolymers. 66:3-18.
39. Cooper, M. A. 2003. Label-free screening of bio-molecular interactions. Anal. Bioanal. Chem. 377:834-842.
40. Henriques, S. T., and M. A. Castanho. 2004. Consequences of nonlytic membrane perturbation to the translocation of the cell penetrating peptide pep-1 in lipidic vesicles. Biochemistry. 43:9716-9724.
41. Caputo, G. A., and E. London. 2003. Using a novel dual fluorescence quenching assay for measurement of tryptophan depth within lipid bilayers to determine hydrophobic α-helix locations within membranes. Biochemistry. 42:3265-3274.
42. Gross, E., R. S. Bedlack Jr., and L. M. Loew. 1994. Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential. Biophys. J. 67:208-216.
43. Cladera, J., and P. O'Shea. 1998. Intramembrane molecular dipoles affect the membrane insertion and folding of a model amphiphilic peptide. Biophys. J. 74:2434-2442.
44. Tagliavini, F., F. Prelli, L. Verga, G. Giaccone, R. Sarma, P. Gorevic, B. Ghetti, F. Passerini, E. Ghibaudi, G. Forloni, et al. 1993. Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro. Proc. Natl. Acad. Sci. USA. 90:9678-9682.
45. Groenning, M., L. Olsen, M. van de Weert, J. M. Flink, S. Frokjaer, and F. S. Jorgensen. 2007. Study on the binding of Thioflavin T to β-sheet-rich and non-β-sheet cavities. J. Struct. Biol. 158:358-369.
46. Inouye, H., and D. A. Kirschner. 2000. A β fibrillogenesis: kinetic parameters for fibril formation from Congo red binding. J. Struct. Biol. 130:123-129.
47. Inouye, H., and D. A. Kirschner. 2005. Alzheimer's β-amyloid: insights into fibril formation and structure from Congo red binding. Subcell. Biochem. 38:203-224.
48. Gennis, R. B. 1989. Biomembranes Molecular Structure and Function. Springer-Verlag, New York.
49. Zhao, H., E. K. Tuominen, and P. K. Kinnunen. 2004. Formation of amyloid fibers triggered by phosphatidylserine-containing membranes. Biochemistry. 43:10302-10307.
50. Taraboulos, A., M. Scott, A. Semenov, D. Avrahami, L. Laszlo, and S. B. Prusiner. 1995. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell Biol. 129:121-132.
51. Bate, C., M. Salmona, L. Diomede, and A. Williams. 2004. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. J. Biol. Chem. 279:14983-14990.
52. Reyes Mateo, C., A. Ulises Acuna, and J. C. Brochon. 1995. Liquid-crystalline phases of cholesterol/lipid bilayers as revealed by the fluorescence of trans-parinaric acid. Biophys. J. 68:978-987.
53. Choo-Smith, L. P., W. Garzon-Rodriguez, C. G. Glabe, and W. K. Surewicz. 1997. Acceleration of amyloid fibril formation by specific binding of Aβ-(1-40) peptide to ganglioside-containing membrane vesicles. J. Biol. Chem. 272:22987-22990.
54. Choo-Smith, L. P., and W. K. Surewicz. 1997. The interaction between Alzheimer amyloid β (1-40) peptide and ganglioside GM1-containing membranes. FEBS Lett. 402:95-98.
55. Kakio, A., S. Nishimoto, K. Yanagisawa, Y. Kozutsumi, and K. Matsuzaki. 2002. Interactions of amyloid β-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry. 41:7385-7390.
56. Chi, E. Y., S. L. Frey, and K. Y. Lee. 2007. Ganglioside G(M1)-mediated amyloid-β fibrillogenesis and membrane disruption. Biochemistry. 46:1913-1924.
57. Shi, J., T. Yang, S. Kataoka, Y. Zhang, A. J. Diaz, and P. S. Cremer. 2007. GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes. J. Am. Chem. Soc. 129:5954-5961.
58. Tillack, T. W., M. Wong, M. Allietta, and T. E. Thompson. 1982. Organization of the glycosphingolipid asialo-GM1 in phosphatidylcholine bilayers. Biochim. Biophys. Acta. 691:261-273.
59. Magzoub, M., A. Pramanik, and A. Graslund. 2005. Modeling the endosomal escape of cell-penetrating peptides: transmembrane pH gradient driven translocation across phospholipid bilayers. Biochemistry. 44:14890-14897.
60. Whittingham, J. L., D. J. Scott, K. Chance, A. Wilson, J. Finch, J. Brange, and G. Guy Dodson. 2002. Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation. J. Mol. Biol. 318:479-490.
61. Seelig, J. 2004. Thermodynamics of lipid-peptide interactions. Biochim. Biophys. Acta. 1666:40-50.
62. White, S. H., and W. C. Wimley. 1998. Hydrophobic interactions of peptides with membrane interfaces. Biochim. Biophys. Acta. 1376:339-352.
63. Magzoub, M., and A. Graslund. 2004. Cell-penetrating peptides: [corrected] from inception to application. Q. Rev. Biophys. 37:147-195.
64. Henriques, S. T., M. N. Melo, and M. A. Castanho. 2006. Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem. J. 399:1-7.
65. Magzoub, M., S. Sandgren, P. Lundberg, K. Oglecka, J. Lilja, A. Wittrup, L. E. Goran Eriksson, U. Langel, M. Belting, and A. Graslund. 2006. N-terminal peptides from unprocessed prion proteins enter cells by macropinocytosis. Biochem. Biophys. Res. Commun. 348:379-385.
66. Kazlauskaite, J., N. Sanghera, I. Sylvester, C. Venien-Bryan, and T. J. Pinheiro. 2003. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry. 42:3295-3304.
67. Sanghera, N., and T. J. Pinheiro. 2002. Binding of prion protein to lipid membranes and implications for prion conversion. J. Mol. Biol. 315:1241-1256.